p38 MAPK signalling cascades in inflammatory disease

Gum, 1998, Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket, J. Biol. Chem., 273, 15605, 10.1074/jbc.273.25.15605 Hale, 1999, Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ and δ in inflammatory cell lineages, J. Immunol., 162, 4246, 10.4049/jimmunol.162.7.4246 LoGrasso, 1997, Kinetic mechanism for p38 MAP kinase, Biochemistry, 36, 10422, 10.1021/bi9706778 Zu, 1998, p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation, J. Immunol., 160, 1982, 10.4049/jimmunol.160.4.1982 Wang, 1997, Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase, J. Biol. Chem., 272, 23668, 10.1074/jbc.272.38.23668 Lee, 1994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature, 372, 739, 10.1038/372739a0 Kumar, 1997, Novel homologs of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles, Biochem. Biophys. Res. Commun., 235, 533, 10.1006/bbrc.1997.6849 Moriguchi, 1997, A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses, EMBO J., 16, 7045, 10.1093/emboj/16.23.7045 Yuasa, 1998, J. Biol. Chem., 273, 22681, 10.1074/jbc.273.35.22681 Stein, 1997, p38-2, a novel mitogen-activated protein kinase with distinct properties, J. Biol. Chem., 272, 19509, 10.1074/jbc.272.31.19509 Goedert, 1997, Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases, EMBO J., 16, 3563, 10.1093/emboj/16.12.3563 Deak, 1998, Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB, EMBO J., 17, 4426, 10.1093/emboj/17.15.4426 El Benna, 1996, Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK, Arch. Biochem. Biophys., 334, 395, 10.1006/abbi.1996.0470 Proost, 1996, The role of chemokines in inflammation, Int. J. Clin. Lab. Res., 26, 211, 10.1007/BF02602952 Hidari, 1997, Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils, J. Biol. Chem., 272, 28750, 10.1074/jbc.272.45.28750 Read, 1997, Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-jun N-terminal kinase/p38 mitogen-activated protein kinase pathways, J. Biol. Chem., 272, 2753, 10.1074/jbc.272.5.2753 Nick, 1999, Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils, J. Clin. Invest., 103, 851, 10.1172/JCI5257 Bauer, 1997, Activation of stress-activated protein kinase is a mechanism of priming in macrophages, Surg. Forum, 48, 43 Ridley, 1997, Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels, J. Immunol., 158, 3165, 10.4049/jimmunol.158.7.3165 Knall, 1996, Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils, J. Biol. Chem., 271, 2832, 10.1074/jbc.271.5.2832 Detmers, 1998, Role of stress-activated mitogen-activated protein kinase (p38) in β2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst, J. Immunol., 161, 1921, 10.4049/jimmunol.161.4.1921 Jones, 1998, Two signaling mechanisms for activation of αMβ2 avidity in polymorphonuclear neutrophils, J. Biol. Chem., 273, 10556, 10.1074/jbc.273.17.10556 Pietersma, 1997, p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level, Biochem. Biophys. Res. Commun., 230, 44, 10.1006/bbrc.1996.5886 Knall, 1997, Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases, Proc. Natl. Acad. Sci. U. S. A., 94, 3052, 10.1073/pnas.94.7.3052 Hannigan, 1998, The role of p38 MAP kinase in TGF-β1-induced signal transduction in human neutrophils, Biochem. Biophys. Res. Commun., 246, 55, 10.1006/bbrc.1998.8570 Jorres, 1997, Oxidative stress in COPD, Eur. Respir. Rev., 7, 131 Nick, 1997, Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP, J. Clin. Invest., 99, 975, 10.1172/JCI119263 Partrick, 1997, Role of p38 MAP kinase in human neutrophil priming for superoxide production and elastase release, Surg. Forum, 48, 48 Eder, 1997, Tumor necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all?, Trends Pharmacol. Sci., 18, 319, 10.1016/S0165-6147(97)90657-X Bergmann, 1998, IκBα degradation and nuclear factor κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription. Requirement for an additional activation pathway, J. Biol. Chem., 273, 6607, 10.1074/jbc.273.12.6607 Wesselborg, 1997, Activation of transcription factor NFκB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways, J. Biol. Chem., 272, 12422, 10.1074/jbc.272.19.12422 Badger, 1996, Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function, J. Pharmacol. Exp. Ther., 279, 1453 Wilson, 1997, The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase, Chem. Biol., 4, 423, 10.1016/S1074-5521(97)90194-0 Tong, 1997, A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket, Nat. Struct. Biol., 4, 311, 10.1038/nsb0497-311 Wang, 1998, Structural basis of inhibitor selectivity in MAP kinases, Structure, 6, 1117, 10.1016/S0969-2126(98)00113-0 Frantz, 1998, The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding, Biochemistry, 37, 13846, 10.1021/bi980832y Young, 1997, Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site, J. Biol. Chem., 272, 12116, 10.1074/jbc.272.18.12116 Lisnock, 1998, Molecular basis for p38 protein kinase inhibitor specificity, Biochemistry, 37, 16573, 10.1021/bi981591x Jackson, 1998, Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models, J. Pharmacol. Exp. Ther., 284, 687 Rogers, 1998, Conquering airway inflammation in the 21st century, Drug Discov. Today, 3, 532, 10.1016/S1359-6446(98)01271-9 Han, 1995, Molecular cloning of human p38 MAP kinase, Biochim. Biophys. Acta, 1265, 224, 10.1016/0167-4889(95)00002-A Galcheva-Gargova, 1994, An osmosensing signal transduction pathway in mammalian cells, Science, 265, 806, 10.1126/science.8047888 Jiang, 1996, Characterization of the structure and function of a new mitogen-activated protein kinase (p38β), J. Biol. Chem., 271, 17920, 10.1074/jbc.271.30.17920 Li, 1996, The primary structure of p38γ: a new member of p38 group of MAP kinases, Biochem. Biophys. Res. Commun., 228, 334, 10.1006/bbrc.1996.1662